These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


168 related items for PubMed ID: 7021427

  • 41. Differential role of T regulatory and Th17 in Swiss mice infected with Plasmodium berghei ANKA and Plasmodium yoelii.
    Keswani T, Bhattacharyya A.
    Exp Parasitol; 2014 Jun; 141():82-92. PubMed ID: 24675415
    [Abstract] [Full Text] [Related]

  • 42. Virulent and nonvirulent forms of Plasmodium yoelii are not restricted to growth within a single erythrocyte type.
    Fahey JR, Spitalny GL.
    Infect Immun; 1984 Apr; 44(1):151-6. PubMed ID: 6368391
    [Abstract] [Full Text] [Related]

  • 43. Lipid antigens derived from erythrocytes infected with Plasmodium berghei.
    Frankenburg S, Slutzky GM, Gitler C, Londner MV.
    Z Parasitenkd; 1984 Apr; 70(3):331-6. PubMed ID: 6377726
    [Abstract] [Full Text] [Related]

  • 44. Antibody-mediated elimination of malaria parasites (plasmodium berghei) in vivo.
    Hamburger J, Kreier JP.
    Infect Immun; 1975 Aug; 12(2):339-45. PubMed ID: 1097338
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Plasmodium berghei: serum-mediated inhibition of infectivity of infected mice to Anopheles stephensi mosquitoes.
    Fleck SL, Butcher GA, Sinden RE.
    Exp Parasitol; 1994 Feb; 78(1):20-7. PubMed ID: 8299757
    [Abstract] [Full Text] [Related]

  • 48. Effect of amphotericin B on parasitemia and survival of plasmodium berghei-infected mice.
    Siraskar B, Ballal A, Bobbala D, Föller M, Lang F.
    Cell Physiol Biochem; 2010 Feb; 26(3):347-54. PubMed ID: 20798519
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Enhancement of resistance to infections by endotoxin-induced serum factor from Mycobacterium bovis BCG-infected mice.
    Parant MA, Parant FJ, Chedid LA.
    Infect Immun; 1980 Jun; 28(3):654-9. PubMed ID: 6772564
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. TNF and inhibition of growth of Plasmodium falciparum.
    Clark IA, Cowden WB, Butcher GA.
    Immunol Lett; 1990 Aug; 25(1-3):175-8. PubMed ID: 2283147
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Lipopolysaccharide-induced cytokine production and mortality in mice treated with Corynebacterium parvum.
    Smith SR, Calzetta A, Bankowski J, Kenworthy-Bott L, Terminelli C.
    J Leukoc Biol; 1993 Jul; 54(1):23-9. PubMed ID: 8336076
    [Abstract] [Full Text] [Related]

  • 56. Inhibitory effect of rhodamine 123 on the growth of the rodent malaria parasite, Plasmodium yoelii.
    Tanabe K.
    J Protozool; 1984 May; 31(2):310-3. PubMed ID: 6470989
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Murine malaria: blood clearance and organ sequestration of Plasmodium yoelii-infected erythrocytes.
    Smith LP, Hunter KW, Oldfield EC, Strickland GT.
    Infect Immun; 1982 Oct; 38(1):162-7. PubMed ID: 7141688
    [Abstract] [Full Text] [Related]

  • 60. Characterising the effect of antimalarial drugs on the maturation and clearance of murine blood-stage Plasmodium parasites in vivo.
    Khoury DS, Cromer D, Elliott T, Soon MSF, Thomas BS, James KR, Best SE, Aogo RA, Engel JA, Gartlan KH, Akter J, Sebina I, Haque A, Davenport MP.
    Int J Parasitol; 2017 Dec; 47(14):913-922. PubMed ID: 28864033
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.